APS

2024 APS Annual Convention · 2024

The Ketogenic Diet Improves Metabolic Markers and Psychiatric Symptoms in Schizophrenia

San Francisco, CA · May 2024

Poster · Biological/Neuroscience

  • Juliette Kyner
    San Francisco VA Medical Center
  • Juliette Kyner
    UCSF
  • Susanna Fryer
    San Francisco VA Medical Center
  • Susanna Fryer
    University of California, San Francisco
  • Daniel Mathalon
    San Francisco Veterans Affairs Health Care System, San Francisco, CA, USA
  • Daniel Mathalon
    Department of Psychiatry, University of California, San Francisco, CA, USA
  • Shebani Sethi
    Stanford University School of Medicine
  • Judith Ford
    San Francisco VA Medical Center
  • Judith Ford
    University of California, San Francisco

Abstract

We assigned participants with psychotic symptoms (n=24) to a ketogenic diet (KD) or an unchanged diet and collected pre- and post-diet data from blood tests, neuropsychological assessments, and symptom assessments. KD participants showed improved metabolic markers, cognitive performance, and symptoms; indicating KD may address metabolic pathology present in psychotic disorders.

Psychopathology

← Poster Session IX